I am a partner at Cooley and at CYL & Partners, a firm of Hong Kong solicitors that practices in association with Cooley HK. My practice focuses on initial public offerings and other equity capital markets transactions on the Hong Kong Stock Exchange, pre-IPO investments, public takeovers and listing rules and securities regulations compliance.
I have actively participated in the strategic initiative by the Hong Kong Stock Exchange to attract new economy companies to list in Hong Kong. In particular, I advised Ascletis Pharma on its US$400 million Hong Kong IPO in 2018, the first pre-revenue biotech IPO on the HKEX under its new listing regime for companies from emerging and innovative sectors. I was listed in IFLR1000 2019 and 2020 as a Notable Practitioner for equity capital markets work.
Why Cooley?
Cooley has an unparalleled collegial and collaborative culture that is unseen anywhere else in the market. Here at Cooley, we are all about the team. Cooley lawyers across all offices globally work together to deliver legal services of the highest quality. I never stopped being inspired or even surprised by the firm’s humanity, compassion and collegiality.
Some of the clients with whom I work
Legend Bio, Ascletis Pharma, Henlius, BabyTree, Cstone, Country Garden Services, and major US, European and Chinese investment banks
Hobbies and interests
Soccer, European art from Renaissance to 1900s, movies
On the weekends, you can find me
On the endless hiking trails across the country parks in Hong Kong or a movie theater or a gym